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Response Kinetics in Chickens
Abstract
Although previous studies have demonstrated an association between interferon-gamma (IFN-gamma)
promoter genotype and antibody response kinetics in chickens, the protein levels that may mediate such a
gene-trait association have not been determined. The objective of this study, therefore, was to determine the
correlation of circulating IFN-gamma levels with both the IFN-gammaIFN-gamma promoter polymorphisms
and antibody response in order to evaluate the potential role of IFN-gamma protein in mediating genetic
control of antibody response in chickens. Antibody response after Salmonella enteritidis (SE) vaccination at
day 10, antibody response to sheep red blood cells (SRBCs) and killed Brucella abortus after immunizations
at 19 wk and 22 wk, and serum IFN-gamma protein level were measured in an F2 population derived from
inbred lines. A single nucleotide polymorphism in the IFN-gamma promoter region was associated with IFN-
gamma protein expression as measured by an enzyme-linked immunosorbent assay after both primary and
secondary immunizations. Higher IFN-gamma protein level was correlated with higher antibody level to SE
and with increased maximum level and decreased time to reach the maximum secondary antibody response to
SRBCs. These results suggest that one of the mechanisms by which promoter polymorphism of IFN-gamma
affects antibody production in chickens may involve the circulating level of IFN-gamma protein.
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SUMMARY. Although previous studies have demonstrated an association between inter-
feron-gamma (IFN-) promoter genotype and antibody response kinetics in chickens, the
protein levels that may mediate such a gene–trait association have not been determined. The
objective of this study, therefore, was to determine the correlation of circulating IFN- levels
with both the IFN- promoter polymorphisms and antibody response in order to evaluate
the potential role of IFN- protein in mediating genetic control of antibody response in
chickens. Antibody response after Salmonella enteritidis (SE) vaccination at day 10, antibody
response to sheep red blood cells (SRBCs) and killed Brucella abortus after immunizations at
19 wk and 22 wk, and serum IFN- protein level were measured in an F2 population derived
from inbred lines. A single nucleotide polymorphism in the IFN- promoter region was
associated with IFN- protein expression as measured by an enzyme-linked immunosorbent
assay after both primary and secondary immunizations. Higher IFN- protein level was
correlated with higher antibody level to SE and with increased maximum level and decreased
time to reach the maximum secondary antibody response to SRBCs. These results suggest
that one of the mechanisms by which promoter polymorphism of IFN- affects antibody
production in chickens may involve the circulating level of IFN- protein.
RESUMEN. Asociacio´n del genotipo del interfero´n- y los niveles de proteı´na con la
cine´tica de la respuesta de anticuerpos en pollos.
Aunque estudios anteriores han demostrado que existe una relacio´n entre el genotipo del
promotor del gen del interfero´n- (IFN-) y la cine´tica de la respuesta de los anticuerpos en
pollos, los niveles de proteı´na que pueden mediar dicha asociacio´n por tendencia gene´tica
no han sido determinados. Por tanto, el objetivo de este estudio fue la determinacio´n de la
correlacio´n entre los niveles circulantes de IFN- con el polimorfismo del promotor del gen
y la respuesta de los anticuerpos, para ası´ estudiar el papel potencial de la proteı´na IFN-
en la mediacio´n del control gene´tico de la respuesta de los anticuerpos en pollos. Se midio´
la respuesta de los anticuerpos en las aves despue´s de la aplicacio´n de vacunas contra la
Salmonella enteriditis a los 10 dı´as de edad, y despue´s de la aplicacio´n de eritrocitos de ovejas
y la vacunacio´n mediante el uso de una cepa inactivada de Brucella abortus a las 19 y 22
semanas, y tambie´n se midieron los niveles se´ricos de IFN- en una poblacio´n F2 derivada
de lı´neas de aves de alta consanguinidad. El polimorfismo de un solo nucleo´tido en el
promotor del gen que codifica por el IFN- fue asociado a la expresio´n de dicha proteı´na,
lo cual fue medido mediante la te´cnica de inmunoensayo ligado a enzimas (ELISA) despue´s
de inmunizaciones primarias y secundarias. Se pudieron correlacionar niveles ma´s altos de
IFN- con niveles ma´s altos de anticuerpos contra la S. enteriditis, ası´ como con niveles
ma´ximos de anticuerpos ma´s altos y menor tiempo en alcanzar niveles ma´ximos de los mismos
en la respuesta secundaria contra eritrocitos de oveja. Estos resultados sugieren que uno de
los mecanismos por los cuales el polimorfismo del promotor del gen del IFN- afecta los
niveles de produccio´n de anticuerpos en pollos puede deberse a los niveles circulantes de la
proteı´na IFN-.
CCorresponding author.
Journal paper no. J-19534 of the Iowa Agriculture and Home Economics Experiment Station, Ames, IA,
Project no. 2237 and 3521.
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Abbreviations: BA  Brucella abortus; ELISA  enzyme-linked immunosorbent assay;
Equil.  equilibrium phase; FF  homozygote from Fayoumi allele; IFN-  interferon
gamma; Ig  immunoglobulin; LF  heterozygote of both leghorn and Fayoumi alleles; LL
 homozygote from leghorn allele; MAb  monoclonal antibody; MHC  major histocom-
patibility complex; OD  optical density; PBS  phosphate-buffered saline; PBST  phos-
phate-buffered saline containing 0.05% Twees 20; PCR  polymerase chain reaction; RFLP
 restriction fragment length polymorphism; SE  Salmonella enteritidis; SNP  single
nucleotide polymorphism; SRBC  sheep red blood cell; Tmax  time needed to achieve
secondary maximum titers; Tmin  time needed to achieve secondary minimum titers; Y 
primary phase parameter; Ymax  maximum secondary titers, Ymin  minimum secondary
titers.
Interferon-gamma (IFN-), a virus inhibito-
ry molecule, was first reported to be induced
from human leukocytes by phytohemagglutinin
in 1965 (35). IFN-, also known as type II
interferon, is an important immunoregulatory
protein that exerts multiple effects on the de-
velopment, maturation, and function of the im-
mune system. IFN- acts as a mild inhibitor of
proliferation for most cell types, whereas it
stimulates the proliferation of mitogen-activat-
ed primary T cells as well as a variety of T-cell
lines (36). The properties of IFN- include reg-
ulation of several aspects of the immune re-
sponse, stimulation of bactericidal activity of
phagocytes, stimulation of antigen presentation
through class I and class II major histocompat-
ibility complex (MHC) molecules, orchestra-
tion of leukocyte–endothelium interactions, ef-
fects on cell proliferation, and apoptosis
(4,5,7,13,20,30). IFN- also mediates immu-
noenhancement against tumors, bacteria, virus-
es, and parasites (8,10,18,25,26,27,31,40).
An antiviral factor is produced by chicken
thymocytes and spleen cells after stimulation
with mitogens (34). This factor has been de-
fined as chicken IFN- in 1995 (9). Chicken
IFN- is biochemically and functionally ho-
mologous to mammalian IFN-; however, the
chicken IFN- gene has been cloned and char-
acterized, and amino acid sequence identity
with humans is only 35.2% (9,19). Chicken
IFN- plays a primary role in many economi-
cally important poultry disease and antibody re-
sponse (17).
A single nucleotide polymorphism (SNP) in
the promoter of the IFN- gene was found be-
tween two highly inbred chicken lines. This se-
quence polymorphism was previously associated
with primary and secondary antibody response
to both sheep red blood cell (SRBC) and Bru-
cella abortus (BA) antigen in an F2 population
derived from these two inbred lines (38). Re-
sistance to a wide range of diseases may be pro-
vided by selection for correlated antibody re-
sponse to foreign proteins (6). Understanding
relationships between general humoral immune
response and disease resistance will be very ben-
eficial for commercial breeding populations,
which cannot be exposed to infectious agents.
Salmonella enteritidis (SE) is one of a group
of emerging foodborne zoonotic poultry path-
ogens, which is a public health problem to hu-
mans in the world. The special biology of the
SE infection in the avian host makes standard
control measures to SE very difficult. The
transmission of SE is not only vertical from par-
ent to chick but also horizontal through envi-
ronment (28).
An in vitro virus neutralization assay to mea-
sure chicken IFN- production during cell-me-
diated immunity requires the use of live virus
(33). To avoid use of live virus, a simple, spe-
cific, and sensitive in vitro chicken IFN- assay
utilizing mouse monoclonal antibodies in an
enzyme-linked immunosorbent assay (ELISA)
was developed to measure IFN- levels in se-
rum (37). The association of the IFN- pro-
moter-region polymorphism with circulating
IFN- protein level and with SE antibody as
well as associations between circulating IFN-
protein levels and antibody response to SRBCs
and BA are unknown. In the present study, a
monoclonal antibody–based ELISA was used to
investigate associations among IFN- promoter
mutation, antibody response to SE, circulating
IFN- protein levels, and antibody response ki-
netics to SRBCs and BA in chickens.
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MATERIALS AND METHODS
Experimental animals. Genetically distinct,
highly inbred (99%) chicken lines, the leghorn G-
B1 and MHC-congenic Fayoumi M15.2 and M5.1
lines, were used as parental lines (39). One sire from
each Fayoumi line was mated to nine dams each of
the G-B1 line to produce an F1 generation. From F1
offspring of each Fayoumi sire, four sires and eight
dams were used to produce 158 females of an F2
generation. The two separate branches, therefore, of
the F2 population reflect the two MHC congenic Fa-
youmi sires, M5.1 and M15.2 (38).
Antigen administration and sample collec-
tion. At 10 days of age, birds of the F2 population
were vaccinated with SE, and blood samples were
collected 11 days after vaccination. At 19 and 23 wk
of age, the same chickens were injected intramuscu-
larly with SRBCs and BA (38). Blood samples were
obtained from the peripheral vein of the wing of each
bird preceding each immunization, at 7 days after
primary immunization, and at 4, 7, 10, 18, 32, and
63 days after secondary immunization. Sera were col-
lected after centrifuging the blood samples and stored
at 20 C until all assays were run simultaneously.
SE antibody and agglutination assays. The SE
antibodies were measured by a commercial ELISA
with modification as described by Kaiser et al. (16).
This ELISA is a competitive assay, thus antibody re-
sponse to SE was adjusted as follows: Antibody level
 1  (SampleOD630/NegOD630), where SampleOD630 is
the sample optical density (OD) measurement at 630
nm and NegOD630 is the mean of the OD measure-
ments at 630 nm of the three negative controls. The
transformed data represented the relative SE antibody
level in serum. The SRBC and BA antibodies were
assayed by agglutination (29).
IFN- ELISA. Chicken sera collected at 7 days af-
ter primary and secondary immunizations were used
to measure circulating IFN- protein levels by the
direct binding ELISA because significantly elevated
levels of serum IFN- were detected around day 7
postinfection with Eimeria maxima (37). Flat-bot-
tom, 96-well microtiter plates were coated with 60
l of sera in 40 l of 0.1 M sodium carbonate buffer,
pH 9.6, for 18 hr at 4 C, blocked with 200 l of
phosphate-buffered saline (PBS) containing 2% (w/
v) bovine serum albumin for 1 hr at room temper-
ature, and washed three times with PBS containing
0.05% Tween-20 (PBS-T), pH 7.2. One hundred
microliters of anti-chicken IFN- monoclonal anti-
body (Mab) (YC1) was added, incubated 18 hr at 4
C, and washed three times with PBS-T, and bound
antibody was detected at 450 nm with horseradish
peroxidase–conjugated goat anti-mouse immuno-
globulin (Ig)G (HL) (Sigma, St. Louis, MO) and
3,3,5,5-tetramethylbenzidine dihydrochloride by an
automated microtiter plate reader (37). For each
plate, two reference chicken sera and five chicken
IFN- MAb plasmids were measured simultaneously
as controls. Plasmid assay measurements were used to
validate the efficacy of the assay system. Circulating
IFN- protein levels in serum were adjusted by ref-
erence samples as follows because of variations be-
tween different measurements: Protein level 
SampleOD450/RefOD450, where SampleOD450 is the sample
OD measurement at 450 nm and RefOD450 is the
mean of the two reference chicken serum control OD
measurements at 450 nm.
Polymerase chain reaction (PCR)-restriction
fragment length polymorphism (RFLP) for the
chicken IFN- promoter region. There were three
base pair mutations in the chicken IFN- promoter
region between the leghorn and both Fayoumi lines.
A SNP at site -318 was evaluated, by PCR-RFLP
assay with restriction enzyme digestion in the F2 pop-
ulation (38). The three levels of IFN- genotype were
defined as homozygote from leghorn allele (LL), het-
erozygote of both leghorn and Fayoumi alleles (LF),
and homozygote from Fayoumi allele (FF).
Statistical analysis. The analyses of antibody re-
sponse were conducted separately by antigen (SE,
SRBC, and BA) and by phase (primary, secondary,
and equilibrium) for SRBC and BA. The single time-
point measurement taken at 7 days post primary im-
munization was used for the primary phase parame-
ters (Y) for SRBC and BA. The secondary phase pa-
rameters of maximum titers (Ymax), time (Tmax)
needed to achieve maximum titers, minimum titers
(Ymin), and time (Tmin) needed to achieve mini-
mum titers were estimated from seven individual
time-point, post secondary titer values by a nonlinear
regression model (38). The equilibrium phase param-
eter (Equil.) was calculated as the mean of the titers
of the last three sample times.
The JMP program (SAS Institute, Inc., Cary,
NC) was used to conduct the general linear model
test for associations of IFN- genotype with IFN-
serum protein level and SE antibody level; the mul-
tivariate pairwise correlation test was used between
IFN- protein level and SE antibody level or anti-
body parameters to SRBC and BA antigens. Because
grandsire by IFN- protein level and grandsire by SE
antibody interactions (P  0.05, data not shown)
were found, data were thereafter analyzed separately
for F2 individuals derived from the two MHC-con-
genic grandsires.
RESULTS
Main effect of IFN- promoter genotype on
antibody response to SE. The IFN- promoter
polymorphism was associated with SE antibody level
(P  0.04) of F2 offspring of the M15.2 grandsire.
The allelic effect of IFN- genotype on SE antibody
level is presented in Table 1. For F2 offspring of the
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Table 1. IFN- promoter allelic effect (mean 	 SEM) on IFN- protein level and antibody response to
Salmonella enteritidis in F2 offspring of M5.1 and M15.2 grandsires.A
Trait
M5.1 Grandsire
LLB LFC FFD
M15.2 Grandsire
LL LF FF
PL1E
PL2F
SEG
0.84 	 0.07a
1.09 	 0.05a
0.42 	 0.03a
0.74 	 0.05a
0.93 	 0.04b
0.37 	 0.02a
0.75 	 0.05a
0.92 	 0.04b
0.38 	 0.02a
0.81 	 0.04a
0.95 	 0.04a
0.30 	 0.03a
0.60 	 0.04b
0.93 	 0.04a
0.25 	 0.03a
0.61 	 0.05b
0.92 	 0.04a
0.35 	 0.03b
AMeans in a row within a grandsire MHC type with no common lowercase superscript differ significantly
(P  0.05).
BLeghorn homozygote.
CHeterozygote of leghorn and Fayoumi genotype.
DFayoumi homozygote.
EIFN- protein level at 7 days after first injection.
FIFN- protein level at 7 days after second injection.
GAntibody level to Salmonella enteritidis vaccination.
Table 2. Serum IFN- protein level (optical density at 450 nm) in F2 females of an inbred cross.
IFN- protein level 7 days postimmunization
Sample chicken serum
Primary Secondary
Reference chicken serum
Primary Secondary
Range
Mean 	 SEM
0.12–0.66
0.29 	 0.01
0.06–0.27
0.14 	 0.003
0.32–0.49
0.40 	 0.04
0.13–0.16
0.15 	 0.006
M15.2 grandsire, the SE antibody level of Fayoumi
homozygous IFN- promoter SNP hens (0.35) was
higher than the other two allelic combinations (0.30
and 0.25; P  0.05). There were 17% and 40%
increases of the SE antibody level for Fayoumi ho-
mozygous individuals compared with leghorn ho-
mozygous and heterozygous birds, respectively.
Main effect of IFN- promoter genotype on
circulating IFN- protein level. The ranges,
means, and standard errors of the mean of IFN-
protein level with sample sera at 7 days after primary
and secondary immunization and reference chicken
serum are presented in Table 2.
The IFN- promoter polymorphism was associat-
ed with the IFN- protein level at 7 days after pri-
mary immunization (P  0.002) of F2 offspring of
the M15.2 grandsire and at 7 days after secondary
immunization (P  0.002) of F2 offspring of the
M5.1 grandsire. The allelic effect of IFN- genotype
on IFN- protein level is presented in Table 1. For
F2 offspring of the M15.2 grandsire, the IFN- pro-
tein level of leghorn homozyous IFN- promoter
SNP (LL) hens (0.81) at 7 days after primary im-
munization was higher (33%) than the other two al-
lelic combinations (0.60 and 0.61; P  0.002). For
F2 offspring of the M5.1 grandsire, in contrast, the
leghorn homozygous IFN- promoter type (LL)
(1.09) had a higher (18%) IFN- protein level at 7
days after secondary immunization than hens from
the other two allelic combinations (0.93 and 0.92; P
 0.05).
Phenotypic correlation of chicken IFN- pro-
tein level with antibody production. IFN- pro-
tein level after primary immunization was positively
correlated with IFN- protein level after post sec-
ondary immunization (0.31; P  0.002). Phenotypic
correlations between chicken IFN- protein level and
SE antibody level or antibody parameters of primary,
secondary, and equilibrium phases to SRBC and BA
of all F2 females are shown in Table 3. The IFN-
protein level at 7 days post secondary immunization
was positively correlated with SE antibody level (P 
0.01), maximum titer to SRBC (P  0.02), and equi-
librium antibody response to SRBC (P  0.08) and
negatively correlated with time required to achieve
maximum titer to SRBC (P  0.07) and primary
antibody response to BA (P  0.04). The level of
IFN- protein at 7 days post primary immunization
was positively correlated with time to reach the min-
imum titer to SRBC (P  0.08) and BA (P  0.09)
and negatively correlated with time to achieve the
maximum titer to SRBC (P  0.03).
DISCUSSION
The important role of IFN- has been doc-
umented in many diseases in poultry
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Table 3. Phenotypic correlation between chicken IFN- protein level and antibody response to Salmonella enteritidis, sheep red blood cells, and Brucella
abortus in F2 females of an inbred cross.
SEA
Sheep red blood cells
YB TminC YminD TmaxE YmaxF Equil.G
Brucella abortus
Y Tmin Ymin Tmax Ymax Equil.
PL1H Correlation
P-value
0.09
NSI
0.04
NS
0.12
0.17
0.15
0.08
0.20
0.03
0.10
NS
0.12
0.16
0.06
NS
0.16
0.09
0.05
NS
0.06
NS
0.03
NS
0.11
0.17
PL2J Correlation
P-value
0.20
0.01
0.10
0.20
0.08
NS
0.04
NS
0.16
0.07
0.20
0.02
0.14
0.08
0.17
0.04
0.02
NS
0.07
NS
0.08
NS
0.04
NS
0.02
NS
AAntibody response to Salmonella enteritidis.
BPrimary antibody response.
CTime required to achieve minimum secondary antibody titers.
DMinimum secondary antibody titers.
ETime required to achieve maximum secondary antibody titers.
FMaximum secondary antibody titers.
GEquilibrium phase antibody titers.
HIFN- protein level at 7 days after primary injection.
INS  not significant (P-value  0.20).
JIFN- protein level at 7 days after secondary injection.
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(8,17,18,25,31). Sequence polymorphisms in
the promoter of mammalian IFN- genes have
also been shown to play a role in resistance to
disease (1,32). Disease resistance is often asso-
ciated with higher antibody levels against spe-
cific pathogens, such as Escherichia coli and Pas-
teurella multocida (15,24). Also, after divergent
selection for response to SRBC, the high anti-
body line displayed higher antibody to New-
castle disease virus and greater resistance to Ma-
rek’s disease virus, Eimeria tenella, Mycoplasma
gallisepticum, and Eimeria necatrix than the low
antibody selected line (11,12,14). In chickens,
IFN- promoter polymorphisms have previous-
ly been demonstrated to be associated with
chicken primary and secondary antibody re-
sponse to both SRBC and BA antigens (38).
Thus, the potential role of promoter polymor-
phisms of the chicken IFN- gene in chicken
disease resistance led us to investigate the role
of the IFN- polymorphism in modulating an-
tibody level.
Salmonella bacteria are a major foodborne
infectious pathogen in humans. IFN- plays a
critical role in host defense and intestinal im-
munity against Salmonella typhimurium in the
mouse (2,3). There was positive correlation be-
tween antibody response to SE and circulating
IFN- protein level at both post primary and
post secondary times in the current study. Se-
rum antibody level to SE vaccine has a high
negative genetic correlation with SE burden in
cecal content (16). Therefore, high IFN- pro-
tein level in serum may be associated with re-
duced gastrointestinal SE burden in chickens.
Both IFN- mRNA and protein are ex-
pressed predominantly by T cells and large
granular lymphocytes (36). IFN- affects anti-
gen-presenting cells, T cells, and B cells, each
of which participates in the complex chain of
events after antigen exposure to the immune
system. In mice, blockage of endogenous IFN-
 reduces the level of primary IgM antibody
responses to sheep erythrocytes in vitro. IFN-
is a necessary component of T-cell-derived
helper factors for antibody induction in in vitro
immunization systems, and IFN- stimulates
polyclonal Ig production by resting or activated
human B cells (36). Therefore, expression of
IFN- may affect antibody response via mod-
ulation of antigen presentation. Lymphocytes
need to be activated to produce IFN-, which
involves cooperation of accessory cells, mostly
mononuclear phagocytes (4). Many diverse,
convergent signal transduction pathways have
been implicated in the transcriptional control
of IFN- (36). Therefore, many different ge-
netic and cellular factors control the production
of IFN-. Because the promoter region of a
gene can regulate gene expression, we hypoth-
esized that mutation in the promoter region
would affect IFN- gene expression. The allelic
effects of promoter polymorphism on IFN-
protein level were very consistent, in that birds
with IFN- LL genotype had higher IFN-
protein levels than both other genotypes after
both primary and secondary immunization and
in F2 offspring of both M5.1 and M15.2 grand-
sires.
IFN- production, as a quantitative trait, is
affected by many genetic and nongenetic fac-
tors. On the basis of the general linear model
analysis of IFN- genotype with protein level
in serum, the IFN- promoter polymorphism
determined 15.8% of the phenotypic variation
in IFN- protein level at 7 days after primary
immunization in F2 offspring of the M15.2
grandsire, and 8.5% for IFN- production at 7
days after secondary immunization in F2 off-
spring of the M5.1 grandsire. Accounting for
this large percentage of variation strongly sug-
gests that DNA sequence polymorphism in or
near the IFN- promoter region might influ-
ence IFN- protein level after both primary and
secondary immunizations.
There were consistently negative correlations
of IFN- protein level after secondary immu-
nization with primary antibody response to
SRBC and BA. However, there was a positive
correlation of IFN- protein level after both
primary and secondary immunizations with
maximum secondary antibody response to
SRBC and negative correlations (P  0.03,
0.07) with the time required to achieve maxi-
mum secondary antibody response to SRBC.
These results suggest that augmented IFN-
protein levels can increase maximum secondary
antibody response to SRBC and decrease the
time needed to reach maximum secondary an-
tibody response to SRBC. Thus, exogenous ad-
ministration of IFN- might be an effective
method to increase antibody response to boost-
er (second or later) vaccinations.
The different correlation directions of IFN-
 protein level between the two antibody re-
sponse phases with SRBC antigen might arise
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from the different cell types involved in primary
and secondary antibody production. When a
naive T cell recognizes an antigen-MHC com-
plex on an appropriate antigen-presenting cell
or target, an activated T cell will initiate a pri-
mary immune response. The memory T cell
and B cell, however, are involved in the sec-
ondary immune response (21). The factors re-
lated to IFN- expression and antibody pro-
duction might thus have different effects be-
tween primary and secondary phases of im-
mune response.
The chicken MHC plays an important role
in antibody production (22,23). Interferon-
stimulated response elements mediate the in-
duction of MHC class I expression by type I
and type II IFN. In particular, IFN- regulates
the expression of multiple components in the
MHC class I–restricted antigen presentation
circuit in the human cell line (13). The direc-
tion of allelic effects of the IFN- promoter
genotype on chicken antibody response to SE
was different between the F2 branches produced
from the two MHC-congenic grandsires. This
result suggests a genetic interaction between the
chicken IFN- promoter polymorphism and
MHC haplotype on antibody response to SE
vaccine. Therefore, effects of IFN- polymor-
phism must be defined in the context of the
population’s MHC alleles.
Adequate functioning of the IFN- and mac-
rophage system is essential for innate, as well as
acquired, resistance to infection (4). The results
of the current study, which clearly demonstrat-
ed the relationship of a promoter polymor-
phism with circulating IFN- levels, and also
of IFN- protein levels with antibody response
parameters, sets the stage for enhancement of
humoral immunity via genetic selection of op-
timal IFN- genotypes.
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